Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Pancreatic Neoplasms 3Multiple Myeloma 3Unspecified Adult Solid Tumor, Protocol Specific 2Solid Tumor 2Neoplasms 2Melanoma 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Refractory or Relapsed Solid Tumors 1Recurrence 1Prostatic Neoplasms 1Neoplasms, Plasma Cell 1Malignant Solid Tumour 1Lymphangioleiomyomatosis 1Leukemia, Myeloid, Acute 1Leukemia 1Gastrointestinal Neoplasms 1Estrogen Receptor Positive Breast Cancer 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Bone Metastases 1Adult Solid Neoplasm 1

Interventions

Cyclophosphamide 41fludarabine 31Dexamethasone 27venetoclax 24Cytarabine 22Rituximab 16pembrolizumab 15fludarabine phosphate 14Filgrastim 12Etoposide 12Lenalidomide 11Vincristine 10Gemcitabine 10Azacitidine 10pomalidomide 9Interleukin-2 9Granulocyte Colony-Stimulating Factor 9Doxorubicin 9Calcium Dobesilate 9carfilzomib 8Topotecan 8Nivolumab 8Methotrexate 8Everolimus 8Decitabine 8Bortezomib 8Melphalan 7Cisplatin 7Vorinostat 6Injections 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Recurrence × Hydroxychloroquine × Clear all
NCT02631252 2018-02-23

Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous Leukemia

University of Pittsburgh

Phase 1 Terminated
1 enrolled
Other hematologic neoplasm

Leukemia, Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡